Executive Summary
Sun Pharmaceuticals Industries Ltd filed a writ petition seeking directions for the expeditious disposal of opposition proceedings against Patent No. 257402, which was granted to Novo Nordisk A/S. The court addressed the procedural delay and directed the respondents to furnish the Opposition Board's recommendations within one week, subsequently rescheduling the hearing.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Sun Pharmaceuticals Industries Ltd vs Union Of India & Ors. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
National Research Development Corporation of IndiavsShri O.P. Kathpalia
The appellant (National Research Development Corporation) sought to refer a dispute concerning technical know-how transfer and royalty payments related to hard ferrites under an agreement dated 8th August, 1967. The respondent contested the liability for royalties and failure to file returns. The court dismissed the appeal, holding that the petition was hopelessly time barred due to the parties' conduct and the expiration of the original agreement.
Pfizer Products IncvsD Rawal
The contempt petition was filed by Pfizer Products Inc alleging non-compliance with a previous court order. The respondent submitted an affidavit stating that they had applied to the DCGI for permission to manufacture and market the new drug, Tofacitinib, under New Drugs and Clinical Trial Rules, 2019. They undertook not to commercialize the product until the patent expiry date.
H Lundbeck A/SvsHetero Drug Ltd.
The plaintiffs alleged that the defendants were infringing their patent (IN 227963) by manufacturing and exporting substantial quantities of the anti-depressant drug Vortioxetine. The court found a prima facie case in favour of the plaintiffs, considering the allegations of export and potential use under Section 107 of the Patents Act.
SAP SEvsSAP HANA SERVER ACCESS HYDERABAD AND ORS
The Delhi High Court granted an ex parte ad interim injunction in favor of SAP SE against the defendants. The court found merit in SAP's claims regarding its proprietary software and trademarks ('SAP', 'SAP HANA'). Consequently, the court directed the immediate de-activation of multiple infringing websites and social media accounts, as well as freezing a specific bank account linked to the alleged pirated activities.
Mankind Pharma LimitedvsNisekind Pharma Private Limited
The Delhi High Court granted an ex-parte ad interim injunction in favor of Mankind Pharma Limited against Nisekind Pharma Private Limited. The court found that Mankind, a major player in the Indian pharmaceutical industry, had established a prima facie case regarding trademark infringement. The ruling specifically restrained the defendant from using the name 'NISEKIND PHARMA PRIVATE LIMITED' and any similar mark containing the word element KIND for medicinal preparations, citing potential consumer confusion and dilution of Mankind's well-known marks.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.